Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. BioLight Life Sciences Ltd.
  6. Summary
    BOLT   IL0010952237

BIOLIGHT LIFE SCIENCES LTD.

(BOLT)
 SummaryChartsNewsCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Tel Aviv Stock Exchange
10/19/2021 10/20/2021 10/21/2021 10/24/2021 10/25/2021 Date
12.58 12.48 12.56 12.4 12.54 Last
1443 1241 300 450 250 Volume
+0.80% -0.79% +0.64% -1.27% +1.13% Change
Estimated financial data (e)
Sales 2019 - - -
Net income 2019 -12,6 M -3,94 M -3,94 M
Net cash position 2019 39,5 M 12,4 M 12,4 M
P/E ratio 2019 -3,01x
Yield 2019 -
Sales 2020 0,03  0,01  0,01 
Net income 2020 -13,4 M -4,18 M -4,18 M
Net cash position 2020 50,2 M 15,7 M 15,7 M
P/E ratio 2020 -2,56x
Yield 2020 -
Capitalization 57,2 M 17,9 M 17,9 M
EV / Sales 2019 -
EV / Sales 2020 -512 472 290x
Nbr of Employees 5
Free-Float 43,0%
More Financials
Company
Biolight Life Sciences Ltd, formerly Bio Light Israeli Life Sciences Investments Ltd, is an Israel-based company engaged, through its subsidiaries, in various fields of research and development of pharmaceuticals and medical products and devices. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The Company provides each of the subsidiaries with ongoing support, resources... 
More about the company
All news about BIOLIGHT LIFE SCIENCES LTD.
08/29Biolight Life Sciences Ltd. Reports Earnings Results for the Half Year Ended June 30, 2..
CI
03/21Aeye Health Ltd announced that it has received funding from BioLight Life Sciences Ltd...
CI
03/18Biolight Life Sciences Ltd. Reports Earnings Results for the Full Year Ended December 3..
CI
2020Diagnostear Ltd announced that it has received $3.85 million in funding from Elcam Med..
CI
2020BioLight Life Sciences Ltd. Auditor Raises 'Going Concern' Doubt
CI
2019Tarsius Pharma Ltd announced that it expects to receive $1.5 million in funding from Bi..
CI
2019Sanoculis Ltd. announced that it expects to receive $1.1 million in funding from BioLig..
CI
2019BioLight Life Sciences Ltd. Auditor Raises 'Going Concern' Doubt
CI
2018BioLight Life Sciences Ltd. Auditor Raises 'Going Concern' Doubt
CI
2017A Chinese investor cancelled the acquisition of 45% stake in BioLight Life Sciences Ltd..
CI
More news
News in other languages on BIOLIGHT LIFE SCIENCES LTD.

- No features available -

More news
Chart BIOLIGHT LIFE SCIENCES LTD.
Duration : Period :
BioLight Life Sciences Ltd. Technical Analysis Chart | BOLT | IL0010952237 | MarketScreener
Income Statement Evolution
Managers and Directors
Yaacov Michlin Chief Executive Officer
Itai Bar-Natan Chief Financial Officer
Israel Makov Chairman
Ron Neumann Chief Medical Officer
Ron Abraham Mayron Independent Director
Sector and Competitors